Vadastuximab (Anti-Human CD33 Recombinant Antibody) is a humanized anti-CD33 monoclonal antibody that can be used for the synthesis of the ADC compound Vadastuximab talirine and for the study of acute myeloid leukemia (AML).
Purity:
97.30%
Target:
Immunology/Inflammation related
* VAT and and shipping costs not included. Errors and price changes excepted